| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10x Genomics, Inc. (TXG) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 57 sells. TXG is classified in the Health Care Technology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.07M | $34.06M | - | |
| Other | 432.6K | $13.75M | - | |
| Dir | 368.4K | $11.71M | - | |
| CFO | 297.4K | $9.45M | - | |
| Dir | 85.9K | $2.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2020 | Saxonov Serge80 | Chief Executive Officer | Sale+OE | 10,000 | $151.40 | $1,513,952.91 | -0.2% | |
| Nov 17, 2020 | Stuelpnagel John R89 | Director | Sell | 7,500 | $135.98 | $1,019,862.03 | -0.4% | |
| Nov 3, 2020 | McAnear Justin J.84 | Chief Financial Officer | Sale+OE | 10,000 | $136.57 | $1,365,722.56 | -31.9% | |
| Nov 3, 2020 | Hindson Benjamin J.82 | See Remarks | Sale+OE | 33,750 | $136.68 | $4,612,976.45 | -4.9% | |
| Nov 3, 2020 | Saxonov Serge80 | Chief Executive Officer | Sale+OE | 10,000 | $136.57 | $1,365,701.82 | -0.1% | |
| Nov 3, 2020 | Crutchfield Bradford87 | Chief Commercial Officer | Sale+OE | 17,000 | $136.68 | $2,323,514.98 | -34.5% | |
| Nov 2, 2020 | Stuelpnagel John R89 | Director | Sell | 7,500 | $136.36 | $1,022,664.65 | -0.4% | |
| Oct 16, 2020 | Stuelpnagel John R89 | Director | Sell | 7,500 | $164.26 | $1,231,936.43 | -0.7% | |
| Oct 1, 2020 | Stuelpnagel John R89 | Director | Sell | 7,500 | $125.60 | $941,981.13 | -0.4% | |
| Oct 1, 2020 | Saxonov Serge80 | Chief Executive Officer | Sale+OE | 10,000 | $125.47 | $1,254,721.14 | -0.3% |